“…These sesquiterpenoids have great antiinflammatory potential. A mechanistic study revealed that the potential anti-inflammatory activity of compound chrysanthemulide A (92) appears to be mediated via suppression of an LPS-induced NF-κB pathway and downregulation of MAPK activation [39,61]. In addition, using H9c2 cardiocytes impaired by lipopolysaccharide (LPS), compounds chrysanthguaianolactone D (65), 3α,4α,10β-trihydroxy-8α-acetoxyguai-1,11(13)-dien-6α,12-olide (67), 3α,4α,10β-trihydroxy-8α-acetoxy-11βH-guai-1-en-6α,12-olide (68), 8α-(angelyloxy)-3β,4β-dihydroxy-5αH,6βH,7αH,11αH-guai-1(10)-en-12,6-olide (71), and 3β,4α-dihydroxy-8α-angelyloxy-1(10),11(13)-dien-6β,12-olide (75) exhibited anti-inflammatory activity [33].…”